199 related articles for article (PubMed ID: 25845407)
1. HIV and HCV Medications in End-Stage Renal Disease.
Greenberg KI; Perazella MA; Atta MG
Semin Dial; 2015; 28(4):397-403. PubMed ID: 25845407
[TBL] [Abstract][Full Text] [Related]
2. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Chronic Hepatitis C in Special Populations.
Bunchorntavakul C; Tanwandee T
Gastroenterol Clin North Am; 2015 Dec; 44(4):883-900. PubMed ID: 26600226
[TBL] [Abstract][Full Text] [Related]
4. Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
Beste LA; Green PK; Ioannou GN
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):123-9. PubMed ID: 25503739
[TBL] [Abstract][Full Text] [Related]
5. [Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection].
Macías J; Rivero A
Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():33-6. PubMed ID: 24063901
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
7. HCV and the kidney.
Corouge M; Vallet-Pichard A; Pol S
Liver Int; 2016 Jan; 36 Suppl 1():28-33. PubMed ID: 26725894
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
Aherfi S; Solas C; Motte A; Moreau J; Borentain P; Mokhtari S; Botta-Fridlund D; Dhiver C; Portal I; Ruiz JM; Ravaux I; Bregigeon S; Poizot-Martin I; Stein A; Gérolami R; Brouqui P; Tamalet C; Colson P
J Med Virol; 2014 Nov; 86(11):1868-76. PubMed ID: 25052594
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
10. [Management of HCV-HIV patients].
Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the hepatitis C virus in patients coinfected with HIV.
Khalili M; Proietti N
Gastroenterol Clin North Am; 2004 Sep; 33(3):479-96, vii-viii. PubMed ID: 15324939
[TBL] [Abstract][Full Text] [Related]
12. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
Rodríguez-Torres M
Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
[TBL] [Abstract][Full Text] [Related]
13. Management of HIV and hepatitis virus coinfection.
Mendes-Corrêa M; Núñez M
Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
[TBL] [Abstract][Full Text] [Related]
14. Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV).
Wegzyn CM; Wyles DL
Curr Opin Pharmacol; 2012 Oct; 12(5):556-61. PubMed ID: 22770811
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antivirals for hepatitis C virus infections in patients co-infected with human immunodeficiency virus.
Piroth L
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S75-83. PubMed ID: 22248699
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.
Milazzo L; Cattaneo D; Calvi E; Gervasoni C; Mazzali C; Ronzi P; Peri AM; Ridolfo AL; D'Avolio A; Antinori S
Int J Antimicrob Agents; 2015 May; 45(5):545-9. PubMed ID: 25769784
[TBL] [Abstract][Full Text] [Related]
17. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
18. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
Campos-Varela I; Peters MG; Terrault NA
Clin Infect Dis; 2015 Jan; 60(1):108-16. PubMed ID: 25228702
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
Rodríguez-Torres M
Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
